Mode
Text Size
Log in / Sign up

Meta-analysis finds 3.58% stroke incidence after lung transplant, linked to 3-fold mortality increase

Meta-analysis finds 3.58% stroke incidence after lung transplant, linked to 3-fold mortality increas…
Photo by Joshua Chehov / Unsplash
Key Takeaway
Recognize stroke affects ~3.6% of lung transplant recipients and is associated with a 3-fold mortality increase.

This systematic review and meta-analysis pooled data from 17 observational studies involving 33,175 adult lung transplant recipients to assess the incidence, mortality impact, and risk factors for stroke after transplantation. The primary outcome was the pooled incidence of stroke, with secondary outcomes including mortality impact and risk factors. The study design and follow-up duration were not reported.

The main finding was a pooled stroke incidence of 3.58% (95% CI: 2.86%–4.48%). This corresponds to approximately 1 in 28 recipients. The analysis showed substantial statistical heterogeneity (I² = 69.0%), with a 95% prediction interval for incidence ranging from 1.66% to 7.54%. No association was found between the proportion of bilateral transplants and stroke incidence (p = 0.86).

Regarding mortality, stroke was associated with a 3-fold increase in the adjusted hazard of death (aHR 3.01, 95% CI: 2.67–3.41). Thirty-day mortality was markedly higher in patients with stroke (20%) compared to those without (1.3%), though statistical testing for this comparison was not reported. Safety and tolerability data were not reported.

Key limitations include substantial heterogeneity, primarily attributed to variation in stroke ascertainment methods across the included studies. This meta-analysis synthesizes observational data, reporting associations, not causation. For practice, clinicians should recognize that stroke is a significant complication affecting roughly 1 in 28 lung transplant recipients and is strongly associated with increased mortality. Standardized definitions and prospective studies are needed to better understand risk factors and prevention strategies.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedMar 2026
View Original Abstract ↓
BackgroundStroke represents a significant but understudied complication following lung transplantation. No systematic review has synthesized the evidence on post-transplant stroke incidence and outcomes. This study aimed to determine the pooled incidence of stroke after lung transplantation, explore sources of heterogeneity, and synthesize evidence on mortality impact and risk factors.MethodsWe searched PubMed, Embase, Cochrane Library, and Web of Science from inception to December 2025. Studies reporting stroke incidence in adult lung transplant recipients with extractable numerator and denominator data were included. Random-effects meta-analysis was performed for incidence pooling; mortality and risk factor data were synthesized narratively.ResultsSeventeen studies (33,175 patients) were included. The pooled stroke incidence was 3.58% (95% CI: 2.86%–4.48%), with substantial heterogeneity (I2 = 69.0%; 95% prediction interval: 1.66%–7.54%). Heterogeneity was not explained by geographic region or time window, but was eliminated after exclusion of the single registry study (I2 = 0%), indicating that variation in ascertainment methods was the primary source of between-study variability. Exploratory meta-regression found no association between bilateral transplant proportion and stroke incidence (p = 0.86). Sensitivity analyses yielded consistent results. Two studies reported mortality outcomes: stroke was associated with a 3-fold increase in mortality (adjusted hazard ratio 3.01; 95% CI: 2.67–3.41) and markedly higher 30-day mortality (20% vs. 1.3%). In the largest registry study, multivariable analysis identified postoperative extracorporeal membrane oxygenation (ECMO; adjusted odds ratio 2.98), bilateral transplant (adjusted odds ratio 1.71), low-volume center, and older age as risk factors.ConclusionStroke affects approximately 1 in 28 lung transplant recipients and is associated with 3-fold increased mortality. Standardized definitions and prospective studies are needed to address gaps in risk stratification and prevention.Systematic review registrationhttps://www.crd.york.ac.uk/prospero/display_record.php?RecordID=1236324, identifier [CRD420251236324].
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.